Alpine Acquisition Corp (REVE) Peer Comparison
$10.54
$0.00 (0.00%)As on 18-Apr-2023 09:30EDT
Market cap
$32 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
11
P/B Ratio
1.3
Div. Yield
0 %
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
Market cap ($ Mln) |
32 | 639 | 132 |
Revenue ($ Mln) |
1 | -- | -- |
Net Profit ($ Mln) |
12.64 | 11.01 | -3.30 |
Net Margin (%) |
235.77 | 508.81 | -278.33 |
RoE (%) |
12.18 | 2.01 | -- |
Price to Earnings |
11.04 | 53.63 | -- |
Price-To-Book |
1.34 | 1.12 | -- |
Income Statement ($ Mln)
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Operating Revenue
|
1.10 | 0.00 | 0.00 |
|
Cost of Revenue
|
0.00 | 0.00 | 0.00 |
|
Gross Profit
|
-- | -- | -- |
|
Operating Expenses
|
1.93 | 1.80 | 2.39 |
|
Operating Profit (EBIT)
|
12.72 | -1.80 | -2.39 |
|
Other Income
|
4.26 | 3.39 | 0.50 |
|
Profit before Tax
|
12.72 | 12.70 | -1.89 |
|
Provision for Tax
|
0.08 | -4.56 | -0.50 |
|
Profit after Tax (Net Income)
|
12.64 | 17.27 | -1.39 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
13.20 | 11.01 | -1.37 |
Liabilities ($ Mln)
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Shareholder's Funds
|
103.83 | 559.25 | -4.64 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
5.22 | 9.86 | 3.15 |
|
Current Liabilities
|
2.62 | 2.67 | 2.09 |
|
Total Liabilities
|
110.08 | 564.60 | 108.65 |
Assets ($ Mln)
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Non-Current Assets
|
110.87 | 571.59 | 108.53 |
|
Current Assets
|
0.79 | 0.19 | 0.60 |
|
Total Assets
|
110.08 | 564.60 | 108.65 |
|
Total Debt*
|
2.01 | 0.00 | 1.05 |
|
Net Current Assets
|
-1.82 | -2.48 | -1.49 |
Cashflow ($ Mln)
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Cash From Operating Activities
|
-0.94 | -2.07 | -0.79 |
|
Cash Flow from Investing Activities
|
-119.06 | -614.51 | -107.10 |
|
Cash from Financing Activities
|
110.45 | 565.61 | 108.97 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- |
Ratios
Profitability Ratios
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
ROCE (%)
|
-- | -- | -- |
|
ROE (%)
|
12.18 | 3.13 | -- |
|
ROA (%)
|
11.26 | 3.03 | -1.26 |
|
EBIT Margin (%)
|
1,154.04 | -- | -- |
|
Net Margin (%)
|
235.77 | 508.81 | -278.33 |
|
Cash Profit Margin (%)
|
0.01 | -- | -- |
Growth Ratios
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- |
|
EBIT Growth (%)
|
-- | -118.81 | -- |
|
Net Profit Growth (%)
|
-- | 146.05 | -- |
|
EPS Growth (%)
|
-- | -- | -- |
|
Book Value Growth (%)
|
14.10 | 2,341.69 | -- |
Valuation Ratios
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Price / Earnings
|
-- | -4.27 | -46.74 |
|
Price / Book Value
|
-- | 0.11 | 0.25 |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
-0.06 | -7.78 | -44.83 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.02 | 0.00 | -0.23 |
|
Current Ratio
|
0.30 | 0.07 | 0.29 |
|
Quick Ratio
|
0.30 | 0.07 | 0.29 |
|
Interest Coverage
|
-- | 1.59 | -- |
Operating Efficiency Ratios
| Alpine Acquisition Corp (REVE) | Khosla Ventures Acquisition Co III (KVSC) | Aesther Healthcare Acquisition Corp (AEHA) | |
|---|---|---|---|
|
Debtors to sales (%)
|
2.27 | -- | -- |
|
Asset Turnover
|
0.01 | 0.00 | 0.00 |
|
Receivable days
|
-- | -- | -- |
|
Inventory Days
|
-- | -- | -- |
|
Payable days
|
-- | -- | -- |
|
Cash Conversion Cycle
|
-- | -- | -- |